NACVI-RADS Scores for Assessing Muscle-Invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Medicine, Urology, Medical Imaging, Oncology,
Muscle-Invasive Bladder Cancer   Neoadjuvant Immunotherapy   Multiparametric MRI   NACVI-RADS Scores   Pathologic Complete Response  

Academic Background Muscle-invasive bladder cancer (MIBC) is a highly aggressive malignancy. The standard treatment typically involves cisplatin-based neoadjuvant chemotherapy (NAC) or immunotherapy, followed by radical cystectomy (RC) and bilateral pelvic lymph node dissection. However, radical cystectomy significantly impacts patients’ quality of...